The technology sector is no longer asking what artificial intelligence can do for us. It is asking what AI can do for itself. That shift is already underway. OpenAI has begun describing models as ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Abstract: Time-series forecasting demands efficient modeling of long-range dependencies while maintaining computational practicality. Current methods, particularly deep learning approaches, often ...

Rallybio has swerved away from its Recursion Pharmaceuticals pact, accepting $7.5 million upfront for its share of a preclinical program to extend its cash runway to mid-2027. Exscientia, now part of ...

Abstract: Public transportation is an indispensable part of daily life, and predicting bus travel times has long been a focus in public transportation research. In recent years, the development of ...

So, you want to get good at LeetCode, especially using Java? It’s a common goal for a lot of us trying to land those tech jobs. This guide is all about helping you get there. We’ll go over how to ...

Researchers have found that wild orangutans vocalize with a layered complexity previously thought to be unique to human communication, suggesting a much older evolutionary origin. In groundbreaking ...

In groundbreaking work from The University of Warwick, researchers have found that wild orangutans vocalise with a layered complexity previously thought to be unique to human communication, suggesting ...

Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) are tumbling on Tuesday. The stock lost 10.3% as of 2:50 p.m. ET and was down by as much as 11.8% earlier in the day. The move comes as the S&P 500 ...

Recursion Pharmaceuticals is harnesing the power of artificial intelligence to rapidly develop new drugs. The drugmaker's former lead candidate failed to show evidence of efficacy in a phase 2 study ...